Surgically Targeted Radiation Therapy (STaRT) for Brain Tumors
A cancer patient at Henry Ford with a recurring brain tumor is the first person in Michigan to receive an implanted device as treatment.
41-year-old Thomas Groves II from St. Clair received surgically targeted radiation therapy called GammaTile Therapy. Groves said he hopes this can lead to a medical breakthrough ultimately helping many.
A brain tumor diagnosis can be overwhelming—the research, the treatment decisions, and the emotions. This video was created to help you understand your options for receiving treatment.
Matt Likens describes GammaTile Therapy, GT Medical Technologies’ mission, and how working with Silicon Valley Bank has helped GT Medical achieve their purpose of improving the lives of patients with brain tumors.
Orange Park Medical Center is the first hospital in North Florida to provide a new brain tumor treatment the size of a computer chip.
Physicians from the multi-disciplinary brain tumor treatment team at Mayfield Brain & Spine share their experiences with GammaTile Therapy
Mary, a patient with glioblastoma treated with GammaTile Therapy, and her husband and treating cancer team, share their experiences
Robert, a patient with brain metastases treated with GammaTile Therapy, and his treating cancer team, share their experiences
Physicians from the multi-disciplinary brain tumor treatment team at the Piedmont Brain Tumor Center share their experiences with GammaTile Therapy
Presented in partnership with the Musella Foundation and the Central New Jersey Brain Tumor Support Group, learn about GammaTile Therapy, a Surgically Targeted Radiation Therapy for operable brain tumors.
How It Works: This short animation video describes GammaTile Therapy.